Population
Patients with cardiac transthyretin amyloidosis, including Caucasian patients with wild-type ATTR and…
Design
Review
Authors
Discussion
Loading...
Member takes
Overview
May facilitate earlier recognition of cardiac ATTR amyloidosis; leaves open prospective validation of integrated diagnostic-therapeutic pathways.
Structured PICO
P
Population
Patients with cardiac transthyretin amyloidosis (ATTR), including Caucasian patients with wild-type ATTR and Afro-Caribbean patients with hereditary ATTR V122I type.
This review outlines the clinical features and diagnostic approach for cardiac ATTR amyloidosis, which is increasingly recognized and for which novel therapies are emerging.
Cite This Study
Dungu et al. (2012) studied this question.